| 000 | 01343 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515054553.0 | ||
| 264 | 0 | _c20070227 | |
| 008 | 200702s 0 0 eng d | ||
| 022 | _a1557-2501 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aApplegate, Robert J | |
| 245 | 0 | 0 |
_aBivalirudin and DES: a PCI strategy that pays. _h[electronic resource] |
| 260 |
_bThe Journal of invasive cardiology _cFeb 2007 |
||
| 300 |
_a69-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 |
_aCoronary Artery Disease _xtherapy |
| 650 | 0 | 4 | _aCosts and Cost Analysis |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 |
_aHeparin _xadverse effects |
| 650 | 0 | 4 |
_aHirudins _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aLength of Stay _xeconomics |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 |
_aPeptide Fragments _xadverse effects |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadverse effects |
| 650 | 0 | 4 |
_aSirolimus _xadministration & dosage |
| 650 | 0 | 4 |
_aStents _xeconomics |
| 773 | 0 |
_tThe Journal of invasive cardiology _gvol. 19 _gno. 2 _gp. 69-70 |
|
| 999 |
_c16829112 _d16829112 |
||